Exports of an Indian COVID-19 vaccine halted after WHO finds problems at manufacturing plant
The World Health Organization (WHO) has raised unspecified concerns about the manufacturing of Covaxin, one of India’s home-grown COVID-19 vaccines. On 2 April, WHO said it had found problems during a March inspection of the production facilities of Bharat Biotech, the vaccine’s producer. WHO did not disclose the nature of the problems at the plant, which is located in Hyderabad, in Telangana state. But it said Bharat Biotech has agreed to stop exports of Covaxin and is “developing a corrective and preventive action plan.”